You are here

Smoking tobacco products - material contribution

Document

Malignant neoplasm of the oral cavity and oropharynx and hypopharynx - Smoking tobacco products - material contribution Factor

Last reviewed for CCPS 05 October 2005.

Investigative Documents

Claimant Report - Smoking [CRD905]

Claimant Report - Smoking [CRV905]

Preliminary questions [34928]

30303

the veteran has smoked cigarettes, cigars or pipe tobacco at some time.

34929the veteran has established the causal connection between smoking tobacco products and VEA service for the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx.

34930the veteran has established the causal connection between smoking tobacco products and operational service for the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx.

or

34931the veteran has established the causal connection between smoking tobacco products and eligible service for the clinical onset of malignant neoplasm of the oral cavity, oropharynx or hypopharynx.

Clinical onset and operational service [34930]

34932

the veteran smoked at least 2.5 pack years of cigarettes or the equivalent thereof in other tobacco products before the clinical onset of the condition under consideration and, where smoking had ceased, at least some smoking was maintained in the 15 years before the clinical onset of the condition under consideration.

34933

smoking as a causal result of operational service made a material contribution to the SOP requirements for malignant neoplasm of the oral cavity, oropharynx and hypopharynx and smoking tobacco products.

Clinical onset and eligible service [34931]

34938

the veteran smoked at least five pack years of cigarettes or the equivalent thereof in other tobacco products before the clinical onset of the condition under consideration and, where smoking had ceased, at least some smoking was maintained in the 10 years before the clinical onset of the condition under consideration.

34934

smoking as a causal result of eligible service made a material contribution to the SOP requirements for malignant neoplasm of the oral cavity, oropharynx and hypopharynx and smoking tobacco products.